Interactive Interpreter

HAM-D: Hamilton Depression Rating Scale

The HAM-D (Hamilton Depression Rating Scale) is a 17-item clinician-rated scale that measures the severity of depressive symptoms over the past week through a semi-structured interview. The benchmark outcome measure in antidepressant clinical trials, with ≤7 as the remission criterion.

For professional reference, research, and education only. Not for diagnosis or medical advice.

HAM-D Score Interpreter

  • Enter a total score to see its range.

  • 17 items; clinician-rated via semi-structured interview covering the past week. Items scored 0–4 or 0–2 depending on the symptom. Total range 0–52.

    Total score (HAM-D17)Interpretation
    24+Severe depressionScores ≥24 indicate severe depressive illness. Clinically significant impairment is expected; urgent evaluation and treatment review are warranted.
    17–23Moderate depressionScores 17–23 indicate moderate severity. This range typically meets the minimum threshold for entry into antidepressant efficacy trials.
    8–16Mild depressionScores 8–16 indicate mild depressive symptoms. Monitoring and low-intensity interventions may be appropriate depending on clinical context.
    0–7Remission / minimal symptomsScores 0–7 reflect the consensus remission criterion. Residual symptoms may still be present; continued monitoring supports relapse prevention.

    Zimmerman M et al. (2013). J Affect Disord. 150(2):384-8. Severity ranges per empirically derived ROC-based cutoffs. Remission criterion per Frank E et al. (1991). Arch Gen Psychiatry. 48(9):851-5.

The HAM-D (Hamilton Depression Rating Scale) is a 17-item clinician-rated scale for measuring the severity of depression [1]. It is a standard outcome measure in antidepressant trials, where treatment response and remission are defined on its total [2].

What does the HAM-D measure?

The HAM-D (Hamilton Depression Rating Scale), also called the HDRS or HRSD, is a 17-item clinician-administered rating scale developed by Max Hamilton to quantify the severity of depressive illness [1]. It is widely used as an observer-rated outcome measure in antidepressant clinical trials.

Items assess mood, guilt, suicidality, insomnia, work and activity, psychomotor retardation, agitation, anxiety, somatic symptoms, and vegetative features including appetite, libido, and weight. It is particularly sensitive to melancholic features. The HAM-D measures the severity of depressive symptoms in people already identified as depressed; it is not a diagnostic tool.

How do you give the HAM-D?

The HAM-D is administered by a trained clinician through a semi-structured interview, with ratings based on observed behaviour and reported symptoms. It captures symptoms over the past week. Client self-completion is not valid, so it cannot substitute for a self-report questionnaire such as the PHQ-9 in routine screening workflows.

For educational reference only. HAM-D is clinician-administered, scores should be derived from a structured clinical interview, not self-report.

How do you score and interpret the HAM-D?

Items are rated on either a 5-point scale (0–4) or a 3-point scale (0–2), depending on the symptom. The 17-item version (HAM-D17) is standard, yielding total scores from 0 to 52.

HAM-D17 severity ranges recommended by a study of 627 outpatients with major depressive disorder [3]:

Total scoreSeverity
0–7No depression
8–16Mild depression
17–23Moderate depression
≥24Severe depression

A ≥50% reduction from baseline defines treatment response; a score of ≤7 defines remission [2], the two endpoints that anchor FDA antidepressant approval trials. A score of ≤7 reflects minimal residual symptoms but does not confirm full functional recovery.

HAM-D vs PHQ-9

Both measure depression severity, but they serve different purposes and settings.

PHQ-9

  • Client-completed, no clinician time required
  • 9 items, fast for routine screening
  • Suited to primary care and high-volume settings
  • Commonly billed under CPT 96127 when used for measurement-based care
  • Rarely the primary endpoint in antidepressant trials

HAM-D

  • Observer-rated, captures behavioural signs, not just subjective report
  • Standard outcome measure in antidepressant clinical trials
  • Sensitive to melancholic features (vegetative symptoms)
  • Remission criterion (≤7) widely accepted in research
  • Requires a trained clinician, not suitable for self-report

Psychometric properties

  • Severity cutoffs. In 627 outpatients with major depressive disorder, ROC analysis against clinician CGI severity ratings found the HAM-D17 cutoffs that best separated mild from moderate depression (17) and moderate from severe depression (24) [3].
  • Scalability and versions. In a placebo-controlled antidepressant trial, the brief 6-item HAM-D6 was superior to the HAM-D17, HAM-D21 and HAM-D24 in scalability and in separating drug from placebo remission rates; longer versions showed smaller discriminating validity [4].

Limitations

  • Not diagnostic. The HAM-D quantifies severity in people already identified as depressed; diagnosis requires a structured clinical assessment.
  • Clinician time and training. It requires a trained rater and a semi-structured interview, so it is impractical for high-volume screening.
  • Multidimensional total. Longer versions add items that weaken their ability to separate drug from placebo; the 6-item core scale performed better in one trial [4].
  • Cutoff generalizability. The severity ranges come from a single outpatient practice whose participants were mostly white, female and insured [3].

For individuals: This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.

FAQ

  • Is the HAM-D self-report or clinician-administered?

    The HAM-D is clinician-administered, not a self-report measure. A trained clinician conducts a semi-structured interview and assigns ratings based on observed behaviour and reported symptoms. Because self-completion is not valid, it cannot substitute for the PHQ-9 in routine screening workflows.

  • What does a HAM-D score of 7 or below mean?

    A score of ≤7 is the consensus remission criterion established by Frank et al. (1991) and widely adopted as the FDA benchmark in antidepressant approval trials. It reflects minimal residual symptoms, though it does not confirm full functional recovery or absence of future recurrence risk.

  • What are the severity bands for the HAM-D 17-item version?

    Based on Zimmerman et al. (2013), empirically derived bands for the HAM-D17 are: 0–7 (no depression / remission), 8–16 (mild), 17–23 (moderate), and ≥24 (severe). Moderate HAM-D scores (≥17) are typically required for entry into antidepressant efficacy trials.

  • Can the HAM-D be used to diagnose depression?

    No. The HAM-D measures the severity of depressive symptoms in people already identified as depressed — it is not a diagnostic tool. Diagnosis requires a clinical assessment using structured criteria (e.g., DSM-5 or ICD-11); the HAM-D then quantifies symptom burden and tracks change over time.

We help connect the dots, sooner

Learn more

HiBoop does not offer this scale. This page is reference material.This library is an academic and clinical reference. A scale described here is not necessarily offered in HiBoop; each page says whether it is.